Thursday, 5 August 2021

Essential Oil Market Business Developments, Segmentation and Technologies 2021-2028

 Essential Oil | 2021 Scope of Current and Future Industry 


The global essential oils market size is expected to reach USD 33.64 billion by 2028 according to a new study by Polaris Market Research. The report “Essential Oils Market Share, Size, Trends, Industry Analysis Report, By Application (Medical, Food & Beverage, Spa & Relaxation, Fragrances, Cleaning & Home); By Sales Channel (Direct Selling, Others); By Product; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Consumer demand for essential oils is growing owing to its multiple applications such as aroma diffusers or increasing air freshness by adding essential oil drops into the aroma pot. The essential oil has gain popularity in young women’s for making cosmetics at home as it consists of medicinal benefits and natural content.

 

The essential oil has antimicrobial properties which help in preserving the food for a longer period without using synthetic preservatives. This helps the manufacturer increase the shelf life of the products. Increasing demand for safe and natural products is expected to increase the market share for the food & beverages segment across the globe over the forecast period.

 

Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/essential-oil-market/request-for-sample

 

Orange oil gains the largest market share in the year 2020 as it has beauty-enhancing properties and thus it was in high demand for cosmetic applications. As the consumer choices are focus on natural beauty products as an alternative to chemical products the organic oil is expected to drive market growth in the upcoming years.

 

Europe dominated the market for essential oils in the year 2020 as several key players operating in the region. European Federation of Essential oils creates potential opportunities for the industries in the region which acts as a catalyst for the increasing industry growth in the region. Asia pacific has the capacity to gain a larger market share in the forecast period is it consists of new market opportunities and a growing consumer base.

 

Leading players in the essential oil market include Sydney Essential Oil Co. (SEOC), Biolandes SAS, India Essential Oils, Essential Oils of New Zealand, DoTerra, Moksha Lifestyle Products, Young Living Essential Oils, Flavex Naturextrakte GmbH, West India Spices Inc., Ungerer Limited, H. Reynaud & Fils (HRF), Farotti S. R. L., Rocky Mountain Essential Oils, Falcon, The Lebermuth Company. Key market players are focusing on new sales channels and marketing strategies to gain a larger market share.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/essential-oil-market/request-for-discount-pricing

 

 

Polaris Market Research has segmented the essential oils market report on the basis of product, application, sales channel and region:

 

Essential Oils, Product Outlook (Revenue – USD Billion; Volume – Kilo Tons, 2016 – 2028)

  • Orange oil
  • Lemon oil
  • Lime oil
  • Geranium oil
  • Peppermint oil
  • Cornmint oil
  • Eucalyptus oil
  • Jasmine oil
  • Tea tree oil
  • Rosemary oil
  • Citronella oil
  • Spearmint oil
  • Clove leaf oil
  • Lavender oil
  • Other oil types

Essential Oils, Application Outlook (Revenue – USD Billion; Volume – Kilo Tons, 2016 – 2028)

  • Medical
    • Pharmaceutical
    • Nutraceuticals
  • Food & Beverages
    • Bakery
    • Confectionery
    • Dairy
    • RTE meals
    • Beverages
    • Meat, Poultry & Seafood
    • Snacks & Nutritional Bars
  • Spa & Relaxation
    • Aromatherapy
    • Massage Oil
    • Personal Care
  • Cosmetics
    • Hair Care
    • Skin Care
    • Sun Care
    • Makeup & Color Cosmetics
  • Toiletries
    • Soaps
    • Shampoos
    • Men’s Grooming
    • Oral Care
    • Baby Care
  • Fragrances
    • Perfumes
    • Body Sprays
    • Air fresheners
  • Cleaning & Home
    • Kitchen Cleaners
    • Floor Cleaners
    • Bathroom Cleaner
    • Fabric Care

Essential Oils, Sales Channel Outlook (Revenue – USD Billion; Volume – Kilo Tons, 2016 – 2028)

  • Direct Selling
  • Other sales channels

 

Buy Now : https://www.polarismarketresearch.com/checkouts/401

 

Rubber Molding Market Analysis, Impact Of Covid-19 On Sales, Business Opportunities In 2021

 The global rubber molding market size is expected to reach USD 51.42 billion by 2026 according to a new study by Polaris Market Research. The report “Rubber Molding Market Share, Size, Trends, Industry Analysis Report By Type (Injection Molding, Transfer Molding, Compression Molding); By Material (EPDM, SBR, Natural Rubber); By End User (Automotive, Healthcare, Industrial, Sporting Goods); By Regions, Segments & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Molded rubber parts offer excellent performance characteristics and qualities compared to many other materials, which makes it a great choice for a wide range of automotive, healthcare, sports gear and other applications. High demand for automotive tooling among shops supplying the major car makers is creating a demand for new products. Also, these products are highly used in the aerospace industry to perform in extreme pressure and temperature situations on engines and airframes. The companies operating in the rubber molding industry are skilled with industrial mold and they can easily make the transition from industrial products to medical or automotive products as both these industries require similar safety standards.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/rubber-molding-market/request-for-sample

 

Globally, rubber molded products is largely being used in automotive, and other industrial sectors. They have various applications in automotive industry for development of products such as rubber bumpers. These bumpers can reduce wear and tear on body parts and increase the durability of vehicle components. When used in industrial applications, they are formulated to suit high temperature areas, refrigeration seals, weathering, oil, and fuel resistance. Some of the other products produced by using molded rubber include grips and handles, gloves, snorkels and swim fins, earplugs and so on.

  

Use of molding in development of these products provides excellent processing performance, fast cure rates, reduced cycle times and lower production costs. With increasing end use applications, the demand for these products is growing at an advanced rate which has propelled companies to enhance their research and manufacturing capabilities. For instance, in June 2017, Jokey Group extended its international manufacturing footprint with the acquisition of injection molder Treplas SL in Spain. Furthermore, technological advancement also plays a vital role in development of this industry segment. Emergence of robotics and automated manufacturing techniques are driving the growth of this market at a significant rate.

 

Factors such as price volatility, shortage of advanced raw material, and regulatory issues are some of the factors that are likely to restrain the growth of this market during the forecast period. As the application of liquid silicone rubber is increasing in automotive, medical and other markets, the molders are experiencing resin shortages. The industry has seen supply shortages caused by a global net reduction in silicone monomer capacity. However, emerging economies and growing presence of international players in the developing and under developed countries is expected to offer significant growth opportunities during the forecast period. Growing population, increasing demand for advanced technologies, rapid development of the automotive industries and growing industrial sectors are providing a new avenue for the players to enhance their business by expanding their global presence.

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/rubber-molding-market/speak-to-analyst

 

The global market is dominated by Asia-Pacific as the automotive industry is this regional segment is growing at a rapid pace. Moreover, increasing adoption of advanced vehicles, growing development in industrial sectors and technological advancements are some additional factors driving the growth of the market in this region. Though, this regional segment experiencing a booming market growth, increasing environmental concerns with adoption of rubber and plastic components, and fluctuating raw material prices are expected to have a negative impact.

 

Furthermore, companies in the North American and European region are strategically strengthening their market presence by adopting expansion, collaborations, acquisitions, agreements and product development as their primary strategies. For instance, in October 2018, Tenneco acquired Federal-Mogul, one of the key players in the US rubber molding industry. Also, various conferences and seminars being held across the globe to create awareness about the advanced technologies and manufacturing processes. For instance, In July 2018, The German Rubber Conference was organized by the Deutsche Keramische Gesellschaft e.V. DKG at the NurnbergMesse GmbH in Nuremberg, Germany.

 

The key players in the market include Freudenberg and Co. Kg, Continental AG, Sumitomo Riko Co. Ltd., NOK Corporation, Federal-Mogul Corporation, Hutchinson SA, Toyoda Gosei Co., Ltd., Trelleborg AB, Bohra Rubber Pvt. Ltd, and Steele Rubber Products among others.

 

Polaris Market research has segmented the Rubber Molding market report on the basis of level, application, material type, product type, product style and region

 

Rubber Molding Type Outlook (Revenue, USD Million, 2016 – 2026)

  • Injection Molding
  • Transfer Molding
  • Compression Molding
  • Others

Rubber Molding Material Outlook (Revenue, USD Million, 2016 – 2026)

  • Ethylene Propylene Diene Monomer (EPDM)
  • Styrene-Butadiene Rubber
  • Natural Rubber
  • Others

Rubber Molding End User Outlook (Revenue, USD Million, 2016 – 2026)

  • Automotive
  • Healthcare
  • Industrial
  • Sporting Goods
  • Others

 

Healthy Snacks Market 2021 Key Stakeholders, Subcomponent Manufacturers, Industry Association 2027

 The global healthy snacks market size is expected to reach USD 40.94 billion by 2028 according to a new study by Polaris Market Research. The report “Healthy Snacks Market Share, Size, Trends, Industry Analysis Report, By Product (Dried Fruit Snacks, Meat Snacks, Cereal and Granola Bars, Nuts and Seeds Snacks, Others); By Distribution Channel (Offline, Online); By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The rapid increase in the obesity rate of the global population majorly drives the growth of the healthy snacks market. Growing concerns regarding healthy eating habits and increasing disposable income in developing regions support the market growth. Consumers are increasingly consuming snacks with a high content of fiber, calcium, protein, whole grains, vitamins, and minerals.

 

There has been an increasing demand for snack products, which enable consumers to maintain weight, provide nutritional requirements, and align with their health goals. Major factors for increased demand include an additional source of protein and other nutrients. However, the high costs of healthy snacks limit the growth of the market. New emerging markets, emerging consumer demographics, and sales through online channels would provide growth opportunities for the healthy snacks market in the coming years.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/healthy-snacks-market/request-for-sample

 

Increasing incidences of health disorders related to obesity have resulted in increased awareness regarding healthy eating habits. The growing digitization and access to information have further increased consumer awareness. Health and fitness consciousness is also increasing in countries such as China and India due to improving lifestyle and changing food habits.

 

Consumers are tracking their nutritional intake, and consuming healthy snacks, thereby supporting market growth. Leading players in the market are also taking initiatives to increase awareness among consumers through health subscriptions and other marketing campaigns.

 

Asia Pacific is expected to grow at the highest CAGR during the forecast period. A significant rise in the obese population has been registered over the past few years in Australia, China, and Japan among others. The obese and geriatric population is increasing in this region, increasing the demand for healthy snacks in the region. The sedentary lifestyle coupled with hectic work schedules is encouraging consumers to adopt healthy snacking options to meet their nutritional requirements.

Increasing awareness regarding the health benefits of healthy snacks and rising disposable incomes in developing countries of this region augment the market growth in the region. Leading global players are expanding their presence in developing nations of China, Japan, India, Indonesia, and Malaysia to tap the growth opportunities offered by these countries.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/healthy-snacks-market/request-for-discount-pricing

 

The various types of healthy snacks include dried fruit snacks, meat snacks, cereal and granola bars, nuts and seeds snacks, and others. The cereal and granola bars segment is expected to lead the market during the forecast period owing to the increasing demand for on-the-go nutritious snacks. Additional features such as better taste and increased filling capacity further encourage its consumptions. These bars provide instant energy, thereby increasing its demand among sportsmen.

The well-known companies profiled in the report include PepsiCo Foods, Nestlé S.A., General Mills, The Kellogg Company, The Kraft Heinz Company, Herbalife Ltd., Nutrisystem Inc., Mondelez International, Inc., Hormel Foods Corporation, Tyson Foods, Inc., Calbee Inc., and B&G Food Inc. among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Polaris Market Research has segmented the healthy snacks market report based on product, distribution channel, and region:

 

Healthy Snacks, Product Outlook (Revenue – USD Billion, 2016 – 2028)

  • Dried Fruit Snacks
  • Meat Snacks
  • Cereal and Granola Bars
  • Nuts and Seeds Snacks
  • Others

Healthy Snacks, Distribution Channel (Revenue – USD Billion, 2016 – 2028)

  • Online
  • Offline

 

Chemiluminescence Immunoassay Market Size, SWOT Analysis, Emerging Trends and Forecast

 Chemiluminescence Immunoassay | 2021 Scope of Current and Future Industry 


The global chemiluminescence immunoassay market is expected to reach USD 10.67 billion by 2027, according to a new study by Polaris Market Research. The report Chemiluminescence Immunoassay Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments {Automated and Semi-automated}, Consumables, Software & Services); By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease); By End Use; By Regions; Segment Forecast, 2020 – 2027 gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global chemiluminescence immunoassay market is driven by few notable factors such as rapid surge in the COVID- 19 cases, the awareness among the people about timely medical attention, and rapidly improving healthcare infrastructure in terms of rapid testing, which in turn, boosting the chemiluminescence immunoassay industry growth. Chemiluminescence immunoassay solutions are also used for detection of numerous severe diseases including autoimmune disease, cancer, and diabetes, among others.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-sample

 

The global chemiluminescence immunoassay industry is segmented on the basis of product, application, end-use, and region. In terms of product, the market is segmented into instruments, consumables, and software and services. Based on application, the market is classified as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease, autoimmune disease, and others. The end-use segment is further divided into hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and others.

  

Segment Highlights

  • The consumables segment of chemiluminescence immunoassay industry accounted for the largest revenue share in 2019 and is expected to continue its dominance over the forecast period. This can be attributed to the increasing demand for stains or reagents in therapeutics such as endocrinology and drug monitoring.
  • Based on application, the infectious diseases segment is projected to constitute almost half of the market by the end of 2027 on account of the aggressive use of chemiluminescence immunoassay solutions in the healthcare industry to check pandemic infection in across the regions.
  • Hospitals segment is expected to account for the largest revenue share by the end of 2027 on account of the increasing footfall in hospitals for the treatment of several infectious diseases and chronic diseases such as cancer driving chemiluminescence immunoassay solutions

 

List of Key Players

  • DiaSorin S.p.A.
  • Hoffmann-La Roche AG
  • Abbott Laboratories
  • Immunodiagnostic Systems
  • Maccura Biotechnology
  • Shenzhen Mindray
  • Beckman Coulter Inc.
  • Others

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-customization

 Polaris Market Research has segmented the chemiluminescence immunoassay market report on the basis of product, application, end-use, and region.

Chemiluminescence Immunoassay, Product Outlook (Revenue – USD Million, 2016 – 2027)

  • Instruments
  • Automated
  • Semi-automated
  • Consumables
  • Software & Services

Chemiluminescence Immunoassay, Application Outlook (Revenue – USD Million, 2016 – 2027)

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Others

Chemiluminescence Immunoassay, End Use Outlook (Revenue – USD Million, 2016 – 2027)

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Chemiluminescence Immunoassay, Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Direct Purchase this Market Research Report Now @ https://www.polarismarketresearch.com/checkouts/7361

Or

Read 

https://www.prnewswire.com/news-releases/global-covid-19-vaccine-packaging--delivery-devices-market-size-us-3-58-billion-by-2028--cagr-20-1-pmr-301297573.html

https:/www.prnewswire.com/news-releases/pea-starch-market-size-worth-150-7-million-by-2028--cagr-7-2-polaris-market-research-301306705.html

https://www.prnewswire.com/news-releases/rubber-processing-chemicals-market-size-worth-7-84-billion-by-2028--cagr-5-3-polaris-market-research-301308798.html

 

 

Mucormycosis Market Quantitative Assessment by Industry Analysis across the Value Chain

 Mucormycosis | 2021 Scope of Current and Future Industry 


The global mucormycosis market size is expected to reach USD 616.1 million by 2028 according to a new study by Polaris Market Research. The report “Mucormycosis Market Share, Size, Trends, Industry Analysis Report; By Diagnosis (Computed Tomography, MRI, Tissue Biopsy); By Treatment (Surgery, Antifungal Drugs, Amphotericin B Therapy, Others); By End-Use; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The emergence of the COVID-19 pandemic along with the increasing cases of blood cancers and diabetes will be the main factors for the growth of the global market during the forecast period. Organ and bone marrow transplantation along with increasing immune-competent patients due to the conditions like HIV will also boost the growth of the global market.

 

COVID-19 has significantly impacted the globe with over 150 million cases detected worldwide. Brazil is the third-worst affected country with more than 15 million cases and India which is clocking more cases than any other country, in May 2021, and has detected more than 20 million cases from the beginning of the pandemic. Mucormycosis cases are increased in the COVID-19 patients who have undergone treatment.

 

Get Sample Copy :  https://www.polarismarketresearch.com/industry-analysis/mucormycosis-market/request-for-sample

 

Steroid drugs are typically used to manage the disease condition in these patients and even though the drugs are effective in treating corona it will lead to weak immune system and blood sugar level and the patients who taken steroid medication are prone to developing mucormycosis.

 

In India, there is an enormous increase in fungal infection, and in few hospitals in urban areas, five to ten people are coming for mucormycosis treatment. Before the pandemic, mucormycosis was very rare and the emergence of COVID-19 is expected to give a major boost to the growth of the global market.

  

Every year nearly 1.8 million hematological cancers are diagnosed across the globe and bone marrow transplantation is a treatment procedure to treat these conditions. The improved technology has resulted in the increased organ transplantation in the market.

 

In the U.S. market alone, nearly, 37,000 organ transplant procedures were conducted, in 2018. Most of the patients who underwent transplant take immunosuppressive drugs which will put them at the risk of developing mucormycosis.

 

Mucormycosis is a deadly fungal disease caused by species such as Rhizopus, Mucor, Saksenaea, Apophysomyces, Lichtheimia, Cunninghamella, Rhizomucor, and others. The mortality rate of mucormycosis ranges from 17 to 66% in patients and the patients who overcome mucormycosis will suffer from blindness and organ dysfunction.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/mucormycosis-market/request-for-discount-pricing

 

Computed tomography (CT), Magnetic resonance imaging (MRI), and tissue biopsy are mainly used in the diagnosis of fungal infection in the market. Amphotericin B therapy, surgery, and antifungal drugs are the main treatment methods to cure mucormycosis.

 

Many new drugs in the market are approved to treat mucormycosis due to the increasing number of fungal infections. For instance, in March 2021, Bharat Serums and Vaccines Limited received Indian regulatory approval (DGCI) for the use of Liposomal Amphotericin B or LAmB for the treatment of mucormycosis.

 

Market Participants such as Biocon Limited, Abbott Laboratories, Cadila Pharmaceuticals Limited, F. Hoffman La Roche, Novartis AG, Merck Sharp and Dohme, Bristol Myers Squibb, Mylan Labs, Bayer AG, Sanofi, Lonza Group, Johnson & Johnson, Gilead Sciences, and Pfizer Inc. are some of the key players operating in the global market.

 

Polaris Market Research has segmented the mucormycosis market report on the basis of diagnosis, treatment, end-use, and region:

 

Mucormycosis, Diagnosis Outlook (Revenue – USD Million, 2016 – 2028)

  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Tissue Biopsy
  • Others

Mucormycosis, Treatment Outlook (Revenue – USD Million, 2016 – 2028)

  • Surgery
  • Antifungal Drugs
  • Posaconazole
  • Isavuconazole
  • Voriconazole
  • Fluconazole
  • Flucytosine
  • Others
  • Amphotericin B Therapy
  • Others

Mucormycosis, End use Outlook (Revenue – USD Million, 2016 – 2028)

  • Hospitals & Clinics
  • Medical Institutes
  • Research Organization
  • Others